Production Of GSK's Ziagen HIV Oral Liquid Medicine : News Photo

Production Of GSK's Ziagen HIV Oral Liquid Medicine

Credit: 
Bloomberg / Contributor
A GlaxoSmithKline Canada Inc. employee labels and packages bottles of Ziagen, an HIV oral liquid medication, on the packaging line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Global sales of existing HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, according to a report by Datamonitor Group earlier this year. Photographer: Norm Betts/Bloomberg via Getty Images
Caption:
A GlaxoSmithKline Canada Inc. employee labels and packages bottles of Ziagen, an HIV oral liquid medication, on the packaging line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Global sales of existing HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, according to a report by Datamonitor Group earlier this year. Photographer: Norm Betts/Bloomberg via Getty Images
Calculate price
View basket
Date created:
December 13, 2010
Editorial #:
107630293
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Licence type:
Rights-managedRights-managed products are licensed with restrictions on usage, such as limitations on size, placement, duration of use and geographic distribution. You will be asked to submit information concerning your intended use of the product, which will determine the scope of usage rights granted.
Collection:
Bloomberg
Max file size:
2,931 x 1,954 px (31.02 x 20.68 cm) - 240 dpi - 1.15 MB
Release info:
Not released.More information
Source:
Bloomberg
Object name:
GLAXO

Keywords

This image is subject to copyright. Getty Images reserves the right to pursue unauthorized users of this image or clip, and to seek damages for copyright violations. To learn more about copyright and Getty Images’ enforcement program, click here. Availability for this image cannot be guaranteed until time of purchase.
A GlaxoSmithKline Canada Inc employee labels and packages bottles of... News Photo 107630293AIDS,Bottle,Business,Canada,Canadian,Corporate Business,Finance,GlaxoSmithKline Canada Inc.,HIV,Headquarters,Healthcare And Medicine,Horizontal,Label,Liquid,Medicine,Mississauga,Occupation,Ontario - Canada,Package,Packaging,The Americas,Toronto,USA,Using Mouth,Working,Ziagen,drugmakerPhotographer Collection: Bloomberg 2010 BloombergA GlaxoSmithKline Canada Inc. employee labels and packages bottles of Ziagen, an HIV oral liquid medication, on the packaging line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Global sales of existing HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, according to a report by Datamonitor Group earlier this year. Photographer: Norm Betts/Bloomberg via Getty Images